Skip to content
Lower risk Drug recall · FDA · Published August 15, 2018

Hetero Labs Montelukast Tablets Recall: Label Mix-Up Risk

Hetero Labs recalls Montelukast Sodium 10mg tablets due to potential Losartan Potassium mix-up in one lot. Check your NDC 31722-726-30, lot MON17384, exp 12/19.

🇺🇸 FDA recall #D-0081-2019DrugHetero Labs ›
Take action

Contact the company

Recalling firmHetero Labs Limited Unit VUnit V (SEZ Unit I in APIIC SEZ), Surv. No. 439-441, 458, Polepally Vill. · Jadcherla Mandal, Mahaboob Nagar, India
✎ GovInfoNow plain-language explainer

Hetero Labs is recalling Montelukast Sodium Tablets 10 mg (30-count) because one lot may contain Losartan Potassium 50 mg instead of the intended medication. This mix-up could cause unintended medication effects if taken. Read more at govinfonow.com/recall/39724-hetero-labs-montelukast-tablets-recall-label-mix-up-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/39724-hetero-labs-montelukast-tablets-recall-label-mix-up-risk · Updated October 6, 2026 · FDA enforcement record: FDA #D-0081-2019

Cite this page

“Hetero Labs Montelukast Tablets Recall: Label Mix-Up Risk.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/39724-hetero-labs-montelukast-tablets-recall-label-mix-up-risk. Based on FDA recall #D-0081-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0081-2019%22&limit=1).

The FDA announced on 2018-08-15 that Hetero Labs Limited is recalling Montelukast Sodium Tablets 10 mg due to a labeling mix-up hazard. The agency said one lot may contain Losartan Potassium instead of the labeled drug. Owners should contact the company for a full refund.

How to tell if you have it

  • Brand: Hetero Labs
  • Product: Montelukast Sodium Tablets 10 mg, 30-count bottle
  • NDC: 31722-726-30
  • Lot #: MON17384
  • Expiration Date: 12/19
  • Manufacturer: Hetero Labs Limited, Unit V
  • Distributed to: U.S.A. Nationwide
  • Units affected: 98016 bottles

The hazard

The FDA said one lot labeled Montelukast Sodium Tablets 10 mg may contain 90 tablets of Losartan Potassium 50 mg instead. This labeling error creates a risk of patients receiving the wrong medication. The recall is classified as Class I, the most serious category.

Context

GovInfoNow's records show Hetero Labs Limited (Unit V) has had six other recalls since 2017-12-22. Recent issues include a 2026-03-26 recall for Pantoprazole Tablets due to discoloration and a 2020-08-06 recall of Losartan Tablets involving bulging tablets. Other recent recalls of similar products include Sun Pharmaceutical Perampanel 6mg Tablets Recall: Label Mix-Up Risk (2026-06-17), Alvogen Thyro-Tabs 150mcg Tablets Recall: Product Mix-Up Risk (2025-12-31), and Annora Pharma Lacosamide Tablets Recall: Possible Selexipag Mix-Up (2026-06-04).

How to tell if you have this one

Check for the NDC code 31722-726-30, lot number MON17384, and expiration date 12/19 on the bottle. This product was manufactured for Camber Pharmaceuticals in the US.

  • Brand
    Hetero Labs
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for NDC 31722-726-30, lot MON17384, and expiration date 12/19 on the bottle.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “U.S.A. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 49 days after the firm started it.

1. Firm started the recall: Aug 15, 201812. Published in FDA’s Enforcement Report: Oct 3, 201823. FDA classified it Class I: Oct 17, 201832018
  1. Firm started the recall
  2. Published in FDA’s Enforcement Report
  3. FDA classified it Class I

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What should I do if I have the recalled product?

The recall does not require immediate action. Check the product label to see if it matches the recalled details.

Similar recalls

Other Hetero Labs recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0081-2019 (August 15, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0081-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA